Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinumtoxin A in EBS and PC
NCT00936533Phase 2Unknown
- Sponsor
- Uppsala University
- Start
- May 2009
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in epidermolysis bullosa simplex (EBS), pachyonychia congenita (PC), sponsored by Uppsala University. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
epidermolysis bullosa simplex (EBS)pachyonychia congenita (PC)
Beyond the preview
Go deeper on NCT00936533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936533.